The effect of self management training based on Pender's model on clinical findings of patients with brucellosis

The effect of self management training based on Pender's health promotion model on clinical findings of patients with brucellosis

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220205053940N1

Enrollment

Registered

2022-02-16

Start date

2022-03-01

Completion date

Unknown

Last updated

2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

brucellosis. Brucellosis

Interventions

Intervention 1: We have an intervention group.Intervention Group Self management training based on Pender's model, which first determines how self management behavior and its deficiencies before the

Eligibility

Sex/Gender

All

Age

16 Years to 55 Years

Inclusion criteria

Inclusion criteria: The patient has brucellosis according to the diagnosis and in the acute stage (less than 3 months from the onset of symptoms) be at most in the first two weeks of drug treatment All or a number of clinical signs and symptoms have fever and pain, fatigue, sweating and anorexia The headline of Wright or Coombs Wright is equal to or greater than 1/80, or the 2ME test is equal to or greater than 1/40 Be under drug treatment in accordance with the national guidelines for controlling brucellosis Lack of mental illnesses according to the client's history and ability to self care Willingness to participate in this study. Capable of speaking, being able to hear and communicate He has not previously attended self management training on brucellosis. Have access to the phone and preferably the Internet at home (if the program is implemented online) and have read and write literacy Not about women in breastfeeding and pregnancy

Exclusion criteria

Exclusion criteria: Not participating in online or in person training group (absence of more than one session) Discontinuation of drug use for medical reasons Dissatisfaction with cooperation in the continuation of the study Client's hospitalization during study Simultaneous participation in similar educational groups

Design outcomes

Primary

Measure	Time frame
Fever, pain, fatigue, appetite. Timepoint: At the beginning of work in both experimental and control groups, measurement of fever, pain, fatigue, appetite, Sweating and 8 weeks later and after the end of drug treatment, reassessment. Method of measurement: Fever with thermometer, Appetite from the first 3 questions of the questionnaire (ADTA), Sweating with the patient's self expression, Pain with visual analog scale (VAS), Fatigue with visual fatigue intensity scale (VAFS).	—

Measure

Time frame

Fever, pain, fatigue, appetite. Timepoint: At the beginning of work in both experimental and control groups, measurement of fever, pain, fatigue, appetite, Sweating and 8 weeks later and after the end of drug treatment, reassessment. Method of measurement: Fever with thermometer, Appetite from the first 3 questions of the questionnaire (ADTA), Sweating with the patient's self expression, Pain with visual analog scale (VAS), Fatigue with visual fatigue intensity scale (VAFS).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Shahla Khosravan

Gonabad University of Medical Sciences

khosravan@gmu.ac.ir+98 51 5722 3028

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026